Nouvelle-Zélande And NotR. L. Savage
List of bibliographic references
Number of relevant bibliographic references: 13.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000532 | Kathryn E. Hally [Nouvelle-Zélande] ; Georgina K. Bird [Nouvelle-Zélande] ; Anne C. La Flamme [Nouvelle-Zélande] ; Scott A. Harding [Nouvelle-Zélande] ; Peter D. Larsen [Nouvelle-Zélande] | Platelets modulate multiple markers of neutrophil function in response to in vitro Toll-like receptor stimulation |
| 000D99 | Brian A. Darlow [Nouvelle-Zélande] | One thing leads to another: Clinical research in neonatology. The 2015 RACP Montgomery Spencer Oration |
| 001321 | Estee Chan [Nouvelle-Zélande] ; Fiona Mcqueen [Nouvelle-Zélande] | Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature |
| 001332 | Niroshini M. Giles [Nouvelle-Zélande] ; Sweta Kumari [Nouvelle-Zélande] ; Bevan P. Gang [Nouvelle-Zélande] ; Chun W. W. Yuen [Australie] ; Emilie M. F. Billaud [Nouvelle-Zélande] ; Gregory I. Giles [Nouvelle-Zélande] | The Molecular Design of S‐Nitrosothiols as Photodynamic Agents for Controlled Nitric Oxide Release |
| 001380 | Noble Kuntworbe [Nouvelle-Zélande] ; Nataly Martini [Nouvelle-Zélande] ; John Shaw [Nouvelle-Zélande] ; Raida Al-Kassas [Nouvelle-Zélande] | Malaria Intervention Policies and Pharmaceutical Nanotechnology as a Potential Tool for Malaria Management |
| 001432 | Lynne M. Chepulis [Nouvelle-Zélande] ; Evelyn Francis [Nouvelle-Zélande] | An Initial Investigation into the Anti-inflammatory Activity and Antioxidant Capacity of alpha-Cyclodextrin-Complexed Manuka Honey |
| 001932 | M R Alley [Nouvelle-Zélande] ; R A Fairley ; D G Martin ; L. Howe ; T. Atkinson | An outbreak of avian malaria in captive yellowheads/mohua (Mohoua ochrocephala). |
| 001A25 | John J. Bowling [États-Unis] ; Hari K. Pennaka [États-Unis] ; Kelly Ivey [États-Unis] ; Subagus Wahyuono [Indonésie] ; Michelle Kelly [Nouvelle-Zélande] ; Raymond F. Schinazi [États-Unis] ; Frederick A. Valeriote [États-Unis] ; David E. Graves [États-Unis] ; Mark T. Hamann [États-Unis] | Antiviral and Anticancer Optimization Studies of the DNA‐binding Marine Natural Product Aaptamine |
| 001B50 | F. Burling [Nouvelle-Zélande] ; J. Ng [Nouvelle-Zélande] ; H. Thein [Nouvelle-Zélande] ; J. Ly [Nouvelle-Zélande] ; M. R. Marshall [Nouvelle-Zélande] ; P. Gow [Nouvelle-Zélande] | Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort |
| 001B74 | Neil J. Mortimer [Royaume-Uni] ; Michael J. Sladden [Royaume-Uni] ; Sarah E. Hill [Nouvelle-Zélande] ; Robin Ac Graham-Brown [Royaume-Uni] | Childhood sarcoidosis presenting with extensive cutaneous lesions, bilateral hilar lymphadenopathy and severe hypercalcaemia |
| 002641 | M. D. Jose [Nouvelle-Zélande] ; D. O. Mcgregor [Nouvelle-Zélande] ; K. L. Lynn [Nouvelle-Zélande] | Renal sarcoidosis in Christchurch, New Zealand 1970–1998 |
| 002771 | Fumitaka Oyama [Japon] ; Nobuyuki Murakami [Nouvelle-Zélande, Japon] ; Yasuo Ihara [Japon] | Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease |
| 003414 | James W. Paxton [Nouvelle-Zélande] | The effect of food on the bioavailability and kinetics of the anticancer drug amsacrine and a new analogue, N‐5‐dimethyl‐9‐[(2‐methoxy‐4‐methylsulphonylamino)phenylamino]‐4 acridinecarboxamide in rabbits |
| This area was generated with Dilib version V0.6.33. |  |